Fig. 2From: Multidisciplinary recommendations for the management of CAR-T recipients in the post-COVID-19 pandemic eraManagement of COVID-19 patients in the short/medium term (< Day + 100) post CAR T-cell infusion. ICU, Intensive care unit; NmAb, neutralizing monoclonal antibodiesBack to article page